PharmaCielo Ltd. (PCLO.V)
- Previous Close
0.1750 - Open
0.1800 - Bid 0.1750 x --
- Ask 0.1800 x --
- Day's Range
0.1700 - 0.1850 - 52 Week Range
0.1050 - 0.2900 - Volume
502,065 - Avg. Volume
157,717 - Market Cap (intraday)
30.669M - Beta (5Y Monthly) 2.48
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0800 - Earnings Date Apr 29, 2024 - May 3, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. PharmaCielo Ltd. has strategic partnership with Benuvia Operations, LLC to manufacture cGMP pharmaceutical-grade CBD isolate and related products. PharmaCielo Ltd. is headquartered in Toronto, Canada.
www.pharmacielo.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: PCLO.V
Performance Overview: PCLO.V
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PCLO.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PCLO.V
Valuation Measures
Market Cap
29.82M
Enterprise Value
46.59M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.75
Price/Book (mrq)
10.70
Enterprise Value/Revenue
16.57
Enterprise Value/EBITDA
-5.19
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-22.86%
Return on Equity (ttm)
-214.57%
Revenue (ttm)
2.81M
Net Income Avi to Common (ttm)
-12.82M
Diluted EPS (ttm)
-0.0800
Balance Sheet and Cash Flow
Total Cash (mrq)
24.17k
Total Debt/Equity (mrq)
602.97%
Levered Free Cash Flow (ttm)
-4.42M